Brilinta 90 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB26FA23Q
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,037
Award facts
- Contract value 100% obligated
- $7,036.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $7,036.64 to AmerisourceBergen Drug Corp for 60 tablets of Brilinta 90 mg on October 30, 2025, with completion required by October 31, 2025. This firm fixed-price delivery order was competitively awarded without set-aside provisions and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), an enterprise pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
Brilinta (ticagrelor) is an antiplatelet medication used primarily for acute coronary syndrome and cardiovascular disease management, making this procurement consistent with the Defense Health Agency's medical supply requirements for military healthcare systems. AmerisourceBergen's comprehensive pharmaceutical distribution capabilities and established competitive track record through DLA support multiple therapeutic domains, enabling the company to fulfill federal medical procurement needs across brand-name medications, generics, vaccines, and specialized medical supplies for military and veteran healthcare systems worldwide.
Quick answers
Who was awarded contract SPE2DB26FA23Q?
SPE2DB26FA23Q was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 30, 2025.
How much is contract SPE2DB26FA23Q worth?
The government has obligated $7,037 on SPE2DB26FA23Q.
Is contract SPE2DB26FA23Q an order under another contract?
Yes. SPE2DB26FA23Q is a delivery order under SPE2DB20D2014, an indefinite delivery contract.
Was contract SPE2DB26FA23Q competed?
The extent of competition for SPE2DB26FA23Q was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award